Resources
10 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 4/19/2021 (updated 4/5/2024)
The present article reviews whether available efficacy and safety data support the pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD) in patients with concurrent substance use disorders (SUD). Arguments for and against treating adult ADHD with active SUD are discussed
Posted 1/26/2021 (updated 4/4/2024)
This webinar was a continuation of the previously scheduled Grant Writing Strategies Webinar- Part 1. Pam Baston provided more practical examples of grant writing strategies and techniques from many successful proposals.
Posted 1/12/2021 (updated 4/4/2024)
During this webinar, Pam Baston, Technical Expert Lead with JBS International, Inc., provided practical examples of grant writing strategies and techniques from many successful proposals. This session included tips for: Reviewing the funding opportunity application, Creating the template and action list, Assembling a team & Creating responsive and competitive proposal sections
Posted 6/17/2021 (updated 4/2/2024)
Importance: Although clinical trials demonstrate the superior effectiveness of medication for opioid use disorder (MOUD) compared with nonpharmacologic treatment, national data on the comparative effectiveness of real-world treatment pathways are lacking.
Objective:To examine associations between opioid use disorder (OUD) treatment pathways and overdose and opioid-related acute care use as proxies for OUD recurrence
Posted 10/12/2020 (updated 3/29/2024)
The present two-fold study “Speed Limits – Harm reduction for people who use stimulants” significantly contributes to closing the gap of knowledge about which existing harm reduction interventions are effective for people who use stimulant drugs.
Posted 6/26/2020 (updated 3/28/2024)
This webinar highlighted national trends and best practices in medication-based treatment for opioid use disorder in corrections. Participants provided an important perspective on efforts to provide the standard of care for people with opioid use disorder.
Posted 5/22/2020 (updated 3/28/2024)
To identify Finnegan Neonatal Abstinence Scoring Tool tems independently associated with the decision to use pharmacologic therapy and to simplify the FNAST while minimizing loss of information for the treatment decision.
Posted 4/14/2020 (updated 3/28/2024)
Cross-sector collaboration between health and human services organizations is increasingly proposed as a promising strategy for addressing social determinants of health.
Posted 7/20/2020 (updated 3/28/2024)
The "Navigating System Cultures across the Sequential Intercept Model (SIM)" webinar, held on June 26, 2020, and hosted by SAMHSA's GAINS Center.
Posted 7/6/2022 (updated 3/27/2024)
This paper illustrates survival models for analysis of trials of substance use treatment programs. It uses public release data from a study of extended-release naltrexone (XR-NTX), relative to buprenorphine-naloxone (BUP-NX).